Parsifal Capital Management, LP Teva Pharmaceutical Industries LTD Transaction History
Parsifal Capital Management, LP
- $1.06 Billion
- Q2 2024
A detailed history of Parsifal Capital Management, LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Parsifal Capital Management, LP holds 6,696,952 shares of TEVA stock, worth $117 Million. This represents 10.31% of its overall portfolio holdings.
Number of Shares
6,696,952
Previous 5,048,300
32.66%
Holding current value
$117 Million
Previous $71.2 Million
52.78%
% of portfolio
10.31%
Previous 5.97%
Shares
2 transactions
Others Institutions Holding TEVA
# of Institutions
617Shares Held
563MCall Options Held
25.2MPut Options Held
5.08M-
Black Rock Inc. New York, NY43MShares$749 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.3MShares$633 Million41.14% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L332.3MShares$564 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$503 Million3.23% of portfolio
-
Exor Capital LLP London, X026.5MShares$461 Million15.49% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...